Anthony Tzeyew Cheung
CIK: 0001998684
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
enGene Holdings Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 30, 2026ENGN
enGene Holdings Inc.
Award(A)DirectStock Option (Right to Buy)
195K shares- - Jan 29, 2025ENGN
enGene Holdings Inc.
Award(A)DirectStock Option (Right to Buy)
250K shares- - Oct 21, 2024ENGN
enGene Holdings Inc.
Award(A)DirectStock Option (Right to Buy)
100K shares-
1-3 of 3 transactions
About CHEUNG ANTHONY TZEYEW
CHEUNG ANTHONY TZEYEW (SEC CIK 0001998684) files insider reports with the SEC as Chief Scientific Officer of enGene Holdings Inc. (ENGN).
Signal8 holds 3 ownership filings by CHEUNG ANTHONY TZEYEW, all Form 4s, filed between Oct 22, 2024 and Feb 3, 2026. Those filings report 3 transactions, from Oct 21, 2024 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CHEUNG ANTHONY TZEYEW's filings is in SAINT-LAURENT, A8.
Recent filings by CHEUNG ANTHONY TZEYEW
Other insiders filing for enGene Holdings Inc. (ENGN)
- Grossman William, Interim Chief Medical Officer
- Chinoporos Constantine, Interim Chief Business Officer
- Richton Kathleen P., SVP, Finance and Treasurer
- Astley-Sparke Philip, Director
- BRUNK GERALD A, Director
- Glickman Richard M, Director